Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and knee arthroplasty: a comprehensive literature review
- PMID: 22220855
- DOI: 10.1517/14656566.2012.652087
Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and knee arthroplasty: a comprehensive literature review
Abstract
Introduction: Concerns regarding risk versus benefit, that is, the possible impact of surgical-site bleeding on post-operative joint infections, have contributed to a continuing debate over recommendations for venous thromboembolism (VTE) prophylaxis in post-surgical orthopedic patients undergoing total hip and knee arthroplasty (THA/TKA).
Areas covered: A comprehensive literature search using MEDLINE covering the period 2004-2009 was conducted, and published studies that focused on THA and TKA and contained data applicable to thromboprophylaxis, post-surgical wound infection and bleeding are reviewed in this paper. The search strategy included various combinations of terms related to lower limb joint arthroplasty, anticoagulant drugs, post-operative bleeding and prosthetic joint infection (wound infection). Methodological constraints included failure in some studies to define an infection, variations among the studies in the definitions of bleeding and differences in the follow-up time for capturing infection and bleeding events. Despite this, this comprehensive review identified observational, 'real-world' data that can contribute in important ways to the existing evidence base.
Expert opinion: There are insufficient data to either confirm or refute the hypothesis that post-operative bleeding is a mediating pathophysiologic factor linking pharmacologic VTE prophylaxis to an increased risk for wound infection. Studies specifically designed to examine the interrelationship between thromboprophylaxis, bleeding and wound infections following THA/TKA are warranted.
Similar articles
-
In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.J Med Econ. 2012;15(4):644-53. doi: 10.3111/13696998.2012.669438. Epub 2012 Mar 12. J Med Econ. 2012. PMID: 22356512
-
A comparison of complications requiring return to theatre in hip and knee arthroplasty patients taking enoxaparin versus rivaroxaban for thromboprophylaxis.Ortop Traumatol Rehabil. 2013 Mar-Apr;15(2):125-9. doi: 10.5604/15093492.1045953. Ortop Traumatol Rehabil. 2013. PMID: 23652532
-
Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.PLoS One. 2017 May 24;12(5):e0178214. doi: 10.1371/journal.pone.0178214. eCollection 2017. PLoS One. 2017. PMID: 28542415 Free PMC article.
-
Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.Ann Pharmacother. 2012 Jan;46(1):79-88. doi: 10.1345/aph.1P626. Epub 2011 Dec 27. Ann Pharmacother. 2012. PMID: 22202495 Review.
-
Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:25S-31S. doi: 10.1177/1076029609340668. Epub 2009 Jul 31. Clin Appl Thromb Hemost. 2009. PMID: 19648146 Review.
Cited by
-
A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal.J Thromb Thrombolysis. 2015 Aug;40(2):231-9. doi: 10.1007/s11239-014-1153-7. J Thromb Thrombolysis. 2015. PMID: 25403952
-
Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study.Clinicoecon Outcomes Res. 2013;5:1-7. doi: 10.2147/CEOR.S39978. Epub 2012 Dec 28. Clinicoecon Outcomes Res. 2013. PMID: 23300348 Free PMC article.
-
Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban.Clin Pharmacol. 2013 Aug 2;5:143-8. doi: 10.2147/CPAA.S26647. eCollection 2013. Clin Pharmacol. 2013. PMID: 23946671 Free PMC article.
-
Risk factors for prosthetic joint infections following total hip arthroplasty based on 33,337 hips in the Finnish Arthroplasty Register from 2014 to 2018.Acta Orthop. 2021 Dec;92(6):665-672. doi: 10.1080/17453674.2021.1944529. Epub 2021 Jul 1. Acta Orthop. 2021. PMID: 34196592 Free PMC article.
-
Patient-Related Risk Factors for Periprosthetic Joint Infection after Total Joint Arthroplasty: A Systematic Review and Meta-Analysis.PLoS One. 2016 Mar 3;11(3):e0150866. doi: 10.1371/journal.pone.0150866. eCollection 2016. PLoS One. 2016. PMID: 26938768 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical